Abbott director receives share and option awards
Abbott Laboratories director Nancy McKinstry reported equity awards rather than open-market trades.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Abbott Laboratories director Nancy McKinstry reported equity awards rather than open-market trades. She received 2,286 restricted stock units that will convert one-for-one into common shares upon separation from service, death, or a change in control under Abbott’s 2026 Incentive Stock Program.
She also received options for 2,305 common shares at an exercise price of $91.86 per share, expiring in 2036. Following these awards, she directly holds 41,010 common shares and 2,305 options.
Insider Trade Summary
Grant/Award: 4,591 shares
Grant/Award
2 txns
Insider
McKinstry Nancy
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Option (right to buy) | 2,305 | $0.00 | $0.00 |
| Grant/Award | Common shares without par value | 2,286 | $0.00 | $0.00 |
Holdings After Transaction:
Option (right to buy) — 2,305 contracts (Direct);
Common shares without par value — 41,010 shares (Direct)
Footnotes (2)
- F1. Restricted stock unit award granted under the Abbott Laboratories 2026 Incentive Stock Program (the "Program"). The award will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).
- F2. Stock option granted under the Program, in a transaction exempt from Section 16 under Rule 16b-3.
Key Figures
RSU award: 2,286 units
Option grant size: 2,305 options
Option exercise price: $91.86 per share
+3 more
6 metrics
RSU award
2,286 units
Restricted stock units under 2026 Incentive Stock Program
Option grant size
2,305 options
Options on common shares granted on 2026-04-24
Option exercise price
$91.86 per share
Exercise price for 2,305 stock options
Option expiration
2036-04-23
Expiration date of stock option grant
Shares held after award
41,010 shares
Total common shares directly held following transactions
Options held after award
2,305 options
Total options directly held following transactions
Key Terms
Restricted stock unit, Incentive Stock Program, Stock option, Section 16, +1 more
5 terms
Restricted stock unit financial
"Restricted stock unit award granted under the Abbott Laboratories 2026 Incentive Stock Program"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
Incentive Stock Program financial
"granted under the Abbott Laboratories 2026 Incentive Stock Program (the "Program")"
Stock option financial
"Stock option granted under the Program, in a transaction exempt from Section 16"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
Section 16 regulatory
"in a transaction exempt from Section 16 under Rule 16b-3"
Section 16 is a U.S. securities law rule that governs the trading and disclosure obligations of company insiders — typically officers, directors and large shareholders — to promote transparency and deter unfair profit-taking. It requires insiders to publicly report their stock trades and allows companies or the issuer to reclaim quick, short-term profits from certain insider trades, like a scoreboard and a refund policy that help investors see and limit possible insider advantage.
Rule 16b-3 regulatory
"exempt from Section 16 under Rule 16b-3"
Rule 16b-3 is a Securities and Exchange Commission regulation that exempts certain routine, pre-approved transactions by company insiders from automatic liability for short-term trading profits. It acts like a safe harbor: if an insider follows a formal plan or the board approves specific transactions in advance, profits from buying and selling company stock within six months are not automatically reclaimed. Investors care because the rule clarifies when insider trades are permissible and reduces uncertainty about potential clawbacks.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Abbott Laboratories (ABT) director Nancy McKinstry report on this Form 4?
Nancy McKinstry reported receiving equity compensation awards, not open-market trades. She was granted 2,286 restricted stock units and options for 2,305 common shares under Abbott’s 2026 Incentive Stock Program, increasing her direct share and option holdings in the company.
What restricted stock unit (RSU) award did Nancy McKinstry receive from Abbott (ABT)?
She received 2,286 restricted stock units granted under Abbott’s 2026 Incentive Stock Program. Each unit will be paid in one Abbott common share on the earlier of her separation from service, death, or a change in control, aligning director compensation with long-term company performance.
What are the key terms of Nancy McKinstry’s Abbott (ABT) stock option grant?
She was granted options on 2,305 common shares at an exercise price of $91.86 per share. The options were granted under Abbott’s 2026 Incentive Stock Program and will expire in 2036, providing long-dated potential equity upside if exercised in the future.
Were Nancy McKinstry’s Abbott (ABT) equity awards exempt from Section 16 rules?
Yes. The filing notes that the stock option grant was made under Abbott’s 2026 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3, which typically covers board-approved, issuer-granted compensation awards to insiders like directors.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates